Rolf Andrew Ramelmeier - Net Worth and Insider Trading

Rolf Andrew Ramelmeier Net Worth

The estimated net worth of Rolf Andrew Ramelmeier is at least $178,470 dollars as of 2024-11-13. Rolf Andrew Ramelmeier is the EVP, Technical Operations of Sangamo Therapeutics Inc and owns about 65,978 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $178,470. Details can be seen in Rolf Andrew Ramelmeier's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rolf Andrew Ramelmeier has not made any transactions after 2020-12-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Rolf Andrew Ramelmeier

Rolf Andrew Ramelmeier Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rolf Andrew Ramelmeier owns 1 companies in total, including Sangamo Therapeutics Inc (SGMO) .

Click here to see the complete history of Rolf Andrew Ramelmeier’s form 4 insider trades.

Insider Ownership Summary of Rolf Andrew Ramelmeier

Ticker	Comapny	Transaction Date	Type of Owner
SGMO	Sangamo Therapeutics Inc	2020-12-31	EVP & Technical Operations

Rolf Andrew Ramelmeier Latest Holdings Summary

Rolf Andrew Ramelmeier currently owns a total of 1 stock. Rolf Andrew Ramelmeier owns 65,978 shares of Sangamo Therapeutics Inc (SGMO) as of December 31, 2020, with a value of $178,470.

Latest Holdings of Rolf Andrew Ramelmeier

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SGMO	Sangamo Therapeutics Inc	2020-12-31	65,978	2.71	178,470

Holding Weightings of Rolf Andrew Ramelmeier

Rolf Andrew Ramelmeier Form 4 Trading Tracker

According to the SEC Form 4 filings, Rolf Andrew Ramelmeier has made a total of 2 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Sangamo Therapeutics Inc is the sale of 2,464 shares on December 31, 2020, which brought Rolf Andrew Ramelmeier around $41,247.

Insider Trading History of Rolf Andrew Ramelmeier

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rolf Andrew Ramelmeier Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Rolf Andrew Ramelmeier Ownership Network

Ownership Network List of Rolf Andrew Ramelmeier

No Data

Ownership Network Relation of Rolf Andrew Ramelmeier

Rolf Andrew Ramelmeier Owned Company Details

What does Sangamo Therapeutics Inc do?

Who are the key executives at Sangamo Therapeutics Inc?

Rolf Andrew Ramelmeier is the EVP & Technical Operations of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .

Sangamo Therapeutics Inc (SGMO) Insider Trades Summary

Over the past 18 months, Rolf Andrew Ramelmeier made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.

Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sangamo Therapeutics Inc Insider Transactions

No Available Data

Rolf Andrew Ramelmeier Mailing Address

Above is the net worth, insider trading, and ownership report for Rolf Andrew Ramelmeier. You might contact Rolf Andrew Ramelmeier via mailing address: 7000 Marina Blvd, Brisbane Ca 94005.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.